Key statistics
As of last trade, Tiziana Life Sciences Ltd (TLSA:NAQ) traded at 0.97, 136.59% above the 52 week low of 0.41 set on Apr 15, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.99 |
---|---|
High | 1.00 |
Low | 0.95 |
Bid | 0.9304 |
Offer | 1.01 |
Previous close | 1.00 |
Average volume | 332.49k |
---|---|
Shares outstanding | 110.66m |
Free float | 78.88m |
P/E (TTM) | -- |
Market cap | 107.34m USD |
EPS (TTM) | -0.1726 USD |
Data delayed at least 15 minutes, as of Nov 21 2024 21:00 GMT.
More ▼
- Tiziana Life Sciences Announces Groundbreaking ALS Trial Grant Awarded by the ALS Association
- Tiziana Life Sciences to Participate in BIO-Europe 2024 to Discuss Recent Clinical Advancements, Including Positive GLP-1 Combination Study Data
- Tiziana Life Sciences Announces Registered Direct Offering of up to approximately $10 Million
- Tiziana Life Sciences Announces Positive Results from Ozempic and Nasal Anti-CD3 Combination Study
- Tiziana Life Sciences Announces $4 Million Grant Awarded by National Institutes of Health to Study Anti-CD3 in Alzheimer’s Disease
- Tiziana Life Sciences Appoints New Chief Executive Officer
- Tiziana Life Sciences Regains Compliance with Nasdaq Listing Minimum Bid Price Rule
- Tiziana Life Sciences Granted FDA Fast Track Designation
- Tiziana Receives $3.4 Million in Non-Dilutive Funding
- Tiziana Life Sciences to Dose First Patient with Moderate Alzheimer’s Disease with Foralumab
More ▼